New Zealand stocks typically offer high dividends compared to other markets and that yield has attracted international investors to the local bourse in a low interest rate environment. That's raised questions about whether firms valuations relative to earnings are getting stretched, however the benchmark S&P/NZX 50 index's price-to-earnings ratio of 15.72 times is still lower than many of its peers, including Australia's S&P/ASX 200 index which has a PE ratio of 19.18 times, China's Shanghai Shenzhen CSI 300 index trading at a PE ratio of 19.39 times, and Wall Street's Standard & Poor's 500 index which was recently at 21.37 times.
The local stock market hasn't completed any new initial public offerings or compliance listings so far this year, although aged care operator Oceana Healthcare has recently signalled plans to raise $200m in an IPO, listing on the NZX and ASX in May. Some $250m of new debt was listed in March, taking the year-to-date tally to $640m.
Listed issuers raised $107m of equity last month across 14 events, taking the year-to-date capital raised to $561m, of which $198m has been via debt.
The value of NZX's equity markets was $117.7b, or 45.1 per cent of gross domestic product, as at March 31, up 1.9 per cent from a year earlier, while the debt market value rose 27 per cent to $26.4b, or 10.1 per cent of GDP.
The stock market had fewer equity securities listed from a year earlier, down 3.5 per cent at 166, while debt listings rose 21 per cent at 110.
NZX's Smartshares and SuperLife funds management business increased total funds under management 17 per cent to $1.83b in March from a year earlier, with a 24 per cent increase in KiwiSaver funds to $640m.
The stock market operator's stock last traded at $1.06 and has edged up 0.6 per cent so far this year, lagging behind the 3.8 per cent gain in the S&P/ASX All Index over the same period.